vs
Side-by-side financial comparison of FENNEC PHARMACEUTICALS INC. (FENC) and Massimo Group (MAMO). Click either name above to swap in a different company.
Massimo Group is the larger business by last-quarter revenue ($21.0M vs $13.8M, roughly 1.5× FENNEC PHARMACEUTICALS INC.). Massimo Group runs the higher net margin — 9.5% vs -34.7%, a 44.2% gap on every dollar of revenue. On growth, FENNEC PHARMACEUTICALS INC. posted the faster year-over-year revenue change (73.8% vs 15.7%). Over the past eight quarters, Massimo Group's revenue compounded faster (-16.5% CAGR vs -26.3%).
Fennec Pharmaceuticals Inc. is a biopharmaceutical firm focused on developing and commercializing therapies to reduce treatment-related side effects in pediatric cancer patients. Its lead product targets chemotherapy-induced ototoxicity, with core North American markets serving oncology providers and vulnerable pediatric patient groups.
Massimo Dutti, S.A. is a Spanish premium clothing retailer specializing in cashmere and wool products, established in 1985 and owned by Spanish multinational company Inditex, the parent company of Zara, Pull&Bear, and other brands.
FENC vs MAMO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $13.8M | $21.0M |
| Net Profit | $-4.8M | $2.0M |
| Gross Margin | — | 41.5% |
| Operating Margin | -18.5% | 13.1% |
| Net Margin | -34.7% | 9.5% |
| Revenue YoY | 73.8% | 15.7% |
| Net Profit YoY | -141.1% | 215.0% |
| EPS (diluted) | $-0.17 | $0.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $13.8M | $21.0M | ||
| Q3 25 | $12.5M | $17.0M | ||
| Q2 25 | $9.7M | $18.9M | ||
| Q1 25 | $8.8M | $14.9M | ||
| Q4 24 | $7.9M | $18.2M | ||
| Q3 24 | $7.0M | $25.6M | ||
| Q2 24 | $7.3M | $35.4M | ||
| Q1 24 | $25.4M | $30.2M |
| Q4 25 | $-4.8M | $2.0M | ||
| Q3 25 | $-638.0K | $1.5M | ||
| Q2 25 | $-3.2M | $77.7K | ||
| Q1 25 | $-1.2M | $-2.1M | ||
| Q4 24 | $-2.0M | $-1.7M | ||
| Q3 24 | $-5.7M | $-2.5M | ||
| Q2 24 | $-5.6M | $2.8M | ||
| Q1 24 | $12.8M | $3.2M |
| Q4 25 | — | 41.5% | ||
| Q3 25 | — | 42.0% | ||
| Q2 25 | — | 36.3% | ||
| Q1 25 | — | 28.4% | ||
| Q4 24 | — | 19.6% | ||
| Q3 24 | — | 27.2% | ||
| Q2 24 | — | 32.5% | ||
| Q1 24 | — | 34.7% |
| Q4 25 | -18.5% | 13.1% | ||
| Q3 25 | -1.5% | 10.5% | ||
| Q2 25 | -28.3% | 0.8% | ||
| Q1 25 | -9.2% | -18.2% | ||
| Q4 24 | -11.8% | -15.4% | ||
| Q3 24 | -74.6% | 1.2% | ||
| Q2 24 | -69.4% | 10.1% | ||
| Q1 24 | 54.2% | 13.2% |
| Q4 25 | -34.7% | 9.5% | ||
| Q3 25 | -5.1% | 9.0% | ||
| Q2 25 | -32.7% | 0.4% | ||
| Q1 25 | -13.3% | -14.0% | ||
| Q4 24 | -25.0% | -9.5% | ||
| Q3 24 | -82.2% | -9.8% | ||
| Q2 24 | -76.5% | 8.0% | ||
| Q1 24 | 50.6% | 10.6% |
| Q4 25 | $-0.17 | $0.05 | ||
| Q3 25 | $-0.02 | $0.04 | ||
| Q2 25 | $-0.11 | $0.00 | ||
| Q1 25 | $-0.04 | $-0.05 | ||
| Q4 24 | $-0.02 | $-0.05 | ||
| Q3 24 | $-0.21 | $-0.06 | ||
| Q2 24 | $-0.20 | $0.07 | ||
| Q1 24 | $0.41 | $0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $36.8M | $5.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $35.5M | $23.7M |
| Total Assets | $70.6M | $51.4M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $36.8M | $5.8M | ||
| Q3 25 | $21.9M | $2.6M | ||
| Q2 25 | $18.7M | — | ||
| Q1 25 | $22.7M | $3.0M | ||
| Q4 24 | $26.6M | $10.2M | ||
| Q3 24 | $40.3M | — | ||
| Q2 24 | $43.1M | — | ||
| Q1 24 | $51.2M | — |
| Q4 25 | — | — | ||
| Q3 25 | $19.4M | — | ||
| Q2 25 | $19.4M | — | ||
| Q1 25 | $19.4M | — | ||
| Q4 24 | $19.3M | — | ||
| Q3 24 | $32.1M | — | ||
| Q2 24 | $31.8M | — | ||
| Q1 24 | $31.3M | — |
| Q4 25 | $35.5M | $23.7M | ||
| Q3 25 | $-4.5M | $21.7M | ||
| Q2 25 | $-7.5M | $20.2M | ||
| Q1 25 | $-5.9M | $19.9M | ||
| Q4 24 | $-5.9M | $21.7M | ||
| Q3 24 | $-5.2M | $22.5M | ||
| Q2 24 | $-1.4M | $24.7M | ||
| Q1 24 | $3.0M | $18.1M |
| Q4 25 | $70.6M | $51.4M | ||
| Q3 25 | $49.3M | $44.4M | ||
| Q2 25 | $44.9M | $45.9M | ||
| Q1 25 | $46.4M | $46.4M | ||
| Q4 24 | $44.9M | $54.9M | ||
| Q3 24 | $58.9M | $57.1M | ||
| Q2 24 | $63.2M | $49.9M | ||
| Q1 24 | $69.2M | $47.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 10.40× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-6.0M | $4.0M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | 2.01× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-6.0M | $4.0M | ||
| Q3 25 | $1.5M | $633.2K | ||
| Q2 25 | $-3.7M | $-1.4M | ||
| Q1 25 | $-4.3M | $-3.3M | ||
| Q4 24 | $-1.5M | $9.1M | ||
| Q3 24 | $-2.2M | $4.7M | ||
| Q2 24 | $-8.4M | $-6.5M | ||
| Q1 24 | $39.0M | $-637.0K |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $9.0M | ||
| Q3 24 | — | $4.6M | ||
| Q2 24 | — | $-6.7M | ||
| Q1 24 | — | $-741.4K |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 49.7% | ||
| Q3 24 | — | 18.1% | ||
| Q2 24 | — | -19.0% | ||
| Q1 24 | — | -2.5% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.2% | ||
| Q3 24 | — | 0.3% | ||
| Q2 24 | — | 0.7% | ||
| Q1 24 | — | 0.3% |
| Q4 25 | — | 2.01× | ||
| Q3 25 | — | 0.41× | ||
| Q2 25 | — | -17.92× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -2.30× | ||
| Q1 24 | 3.04× | -0.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
